688366 昊海生科
交易中 07-03 10:36:40
资讯
新帖
简况
每周股票复盘:昊海生科(688366)注销114.87万股H股
证券之星 · 06-28
每周股票复盘:昊海生科(688366)注销114.87万股H股
昊海生科(688366)披露关于变更持续督导保荐代表人的公告,6月26日股价下跌3.57%
证券之星 · 06-26
昊海生科(688366)披露关于变更持续督导保荐代表人的公告,6月26日股价下跌3.57%
执行董事唐敏捷增持昊海生科(06826)5000股 每股作价16.12港元
智通财经网 · 06-17
执行董事唐敏捷增持昊海生科(06826)5000股 每股作价16.12港元
港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证
智通财经 · 06-04
港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证
昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证
智通财经 · 06-02
昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证
昊海生科(688366)披露因H股股份回购需通知债权人公告,6月1日股价上涨0.99%
证券之星 · 06-01
昊海生科(688366)披露因H股股份回购需通知债权人公告,6月1日股价上涨0.99%
昊海生科:侯永泰辞任执行董事、董事长
美股速递 · 05-29
昊海生科:侯永泰辞任执行董事、董事长
5月25日昊海生科发布公告,股东减持77.47万股
证券之星 · 05-25
5月25日昊海生科发布公告,股东减持77.47万股
每周股票复盘:昊海生科(688366)累计购回374.89万股H股
证券之星 · 05-17
每周股票复盘:昊海生科(688366)累计购回374.89万股H股
昊海生科(688366)披露H股股份购回进展,5月15日股价下跌1.07%
证券之星 · 05-15
昊海生科(688366)披露H股股份购回进展,5月15日股价下跌1.07%
昊海生科风波再起:实控人涉嫌内幕交易,业绩断崖式下滑
新浪证券 · 05-15
昊海生科风波再起:实控人涉嫌内幕交易,业绩断崖式下滑
昊海生科(688366)披露H股购回进展,5月14日股价下跌3.58%
证券之星 · 05-14
昊海生科(688366)披露H股购回进展,5月14日股价下跌3.58%
每周股票复盘:昊海生科(688366)5月6日回购8.52万股H股
证券之星 · 05-10
每周股票复盘:昊海生科(688366)5月6日回购8.52万股H股
昊海生科(688366)发布H股翌日披露报表,5月6日单日回购85,200股H股,5月7日股价下跌0.77%
证券之星 · 05-07
昊海生科(688366)发布H股翌日披露报表,5月6日单日回购85,200股H股,5月7日股价下跌0.77%
每周股票复盘:昊海生科(688366)控股股东因内幕交易被取保候审
证券之星 · 05-02
每周股票复盘:昊海生科(688366)控股股东因内幕交易被取保候审
昊海生科:江伟未在公司担任董事、高级管理人员或其他任何职务
美股速递 · 04-30
昊海生科:江伟未在公司担任董事、高级管理人员或其他任何职务
昊海生科回应江伟涉嫌内幕交易案调查
美股速递 · 04-30
昊海生科回应江伟涉嫌内幕交易案调查
昊海生科实际控制人获上海市公安局取保候审
美股速递 · 04-30
昊海生科实际控制人获上海市公安局取保候审
昊海生科最新公告:控股股东之一因非本公司事项收到《取保候审决定书》
证券之星 · 04-30
昊海生科最新公告:控股股东之一因非本公司事项收到《取保候审决定书》
医美上市企业2025年业绩集体承压!爱美客、昊海生科、巨子生物等营收、净利双降
红星资本局 · 04-28
医美上市企业2025年业绩集体承压!爱美客、昊海生科、巨子生物等营收、净利双降
公司概况
公司名称:
上海昊海生物科技股份有限公司
所属行业:
医药制造业
上市日期:
2019-10-30
主营业务:
上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。本集团的医用几丁糖专利技术先后获得“上海市技术发明一等奖”和“国家科学技术进步奖二等奖”,生产出国际上第一个成功应用于人体内的医用几丁糖产品;外用人表皮生长因子产品获得“国家科学技术进步奖二等奖”,是国际第一个获得注册的外用人表皮生长因子产品;本集团参与研发的“生物适配防粘连材料的关键技术及临床应用”项目获得上海市技术发明奖一等奖。
发行价格:
89.23
{"stockData":{"symbol":"688366","market":"SH","secType":"STK","nameCN":"昊海生科","latestPrice":30.76,"timestamp":1783046200000,"preClose":30.65,"halted":0,"volume":373592,"delay":0,"changeRate":0.0036,"floatShares":194000000,"shares":229000000,"eps":1.0237,"marketStatus":"交易中","change":0.11,"latestTime":"07-03 10:36:40","open":30.65,"high":31.17,"low":30.51,"amount":11544900,"amplitude":0.0215,"askPrice":30.75,"askSize":2,"bidPrice":30.7,"bidSize":2,"shortable":0,"etf":0,"ttmEps":1.0237,"tradingStatus":2,"nextMarketStatus":{"tag":"午间休市","tradingStatus":4,"beginTime":1783049400000},"marketStatusCode":2,"adr":0,"adjPreClose":30.65,"symbolType":"stock_kcb","openAndCloseTimeList":[[1783042200000,1783049400000],[1783054800000,1783062000000]],"highLimit":33.72,"lowLimit":27.59,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":228832195,"isCdr":false,"pbRate":1.29,"roa":"--","peRate":30.047866,"roe":"1.35%","epsLYR":1.08,"committee":0.319149,"marketValue":7039000000,"turnoverRate":0.0019,"status":0,"hkstockBrief":{"symbol":"06826","market":"HK","secType":"STK","nameCN":"昊海生物科技","latestPrice":15.9,"timestamp":1783046211663,"preClose":15.49,"halted":0,"volume":28800,"delay":0,"premium":"-55.29"},"floatMarketCap":5969000000},"requestUrl":"/m/hq/s/688366/wiki","defaultTab":"wiki","newsList":[{"id":"2646231529","title":"每周股票复盘:昊海生科(688366)注销114.87万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2646231529","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646231529?lang=zh_cn&edition=full","pubTime":"2026-06-28 03:43","pubTimestamp":1782589390,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,昊海生科报收于28.61元,较上周的30.15元下跌5.11%。本周,昊海生科6月24日盘中最高价报31.9元。本周关注点公司公告汇总:昊海生科完成注销1,148,700股H股股份,总股本由229,980,895股变更为228,832,195股。公司公告汇总上海昊海生物科技股份有限公司于2026年3月23日至5月15日期间实际回购H股股份1,148,700股,占公司总股本的0.50%,使用资金总额2,547.1688万港元。A股股份占比由84.38%上升至84.80%,H股股份占比由15.62%下降至15.20%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062800001161.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646366535","title":"昊海生科(688366)披露关于变更持续督导保荐代表人的公告,6月26日股价下跌3.57%","url":"https://stock-news.laohu8.com/highlight/detail?id=2646366535","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2646366535?lang=zh_cn&edition=full","pubTime":"2026-06-26 22:55","pubTimestamp":1782485717,"startTime":"0","endTime":"0","summary":"截至2026年6月26日收盘,昊海生科报收于28.61元,较前一交易日下跌3.57%,最新总市值为65.47亿元。该股当日开盘28.97元,最高29.97元,最低28.61元,成交额达1535.83万元,换手率为0.27%。近日,上海昊海生物科技股份有限公司发布《关于变更持续督导保荐代表人的公告》。公告显示,公司接到瑞银证券通知,原持续督导保荐代表人孙利军因工作变动不再担任相关职务,由王依诺接任。公司对孙利军任职期间的贡献表示感谢。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026062600046099.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","BK0251","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2644931743","title":"执行董事唐敏捷增持昊海生科(06826)5000股 每股作价16.12港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2644931743","media":"智通财经网","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2644931743?lang=zh_cn&edition=full","pubTime":"2026-06-17 19:02","pubTimestamp":1781694143,"startTime":"0","endTime":"0","summary":"香港联交所最新数据显示,6月16日,执行董事唐敏捷增持昊海生科(06826)5000股,每股作价16.12港元,总金额约为8.06万港元。","market":"fut","thumbnail":"https://img.zhitongcaijing.com/image/20260617/20260617190330_44960.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250","type":0,"news_type":0,"thumbnails":["https://img.zhitongcaijing.com/image/20260617/20260617190330_44960.png?x-oss-process=image/format,jpg/quality,Q_80/resize,w_250"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1455676.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"highlight_zhitongcaijin","symbols":["BK0251","BK1161","06826","BK1593","EWH","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640158880","title":"港股异动 | 昊海生科(06826)尾盘涨近3% 控股子公司三焦点人工晶状体产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640158880","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640158880?lang=zh_cn&edition=full","pubTime":"2026-06-04 15:54","pubTimestamp":1780559657,"startTime":"0","endTime":"0","summary":"智通财经APP获悉,昊海生科尾盘涨近3%,截至发稿,涨2.87%,报17.87港元,成交额411.34万港元。消息面上,昊海生科公告称,其控股子公司赛美视自主研发的三焦点人工晶状体获得国家药品监督管理局的注册批准。该人工晶状体用于植入囊袋内。该产品是公司本年度获批的又一款多焦点人工晶状体产品,不仅加速并完善了公司在高端多焦点人工晶状体领域的布局,更为眼科业务的发展注入了新动能。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1450077.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK1161","BK0251","BK1574","09996","BK4588","06826","BK1583","BK1593","159883","BK0239","BK4585","VXUS","BK1100","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640591084","title":"昊海生科(688366.SH)控股子公司三焦点人工晶状体产品获得医疗器械注册证","url":"https://stock-news.laohu8.com/highlight/detail?id=2640591084","media":"智通财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640591084?lang=zh_cn&edition=full","pubTime":"2026-06-02 19:35","pubTimestamp":1780400126,"startTime":"0","endTime":"0","summary":"智通财经APP讯,昊海生科 发布公告,公司控股子公司河南赛美视生物科技有限公司于近日收到国家药品监督管理局颁发的关于三焦点人工晶状体产品的《中华人民共和国医疗器械注册证》。该人工晶状体用于植入囊袋内。该产品是公司本年度获批的又一款多焦点人工晶状体产品,不仅加速并完善了公司在高端多焦点人工晶状体领域的布局,更为眼科业务的发展注入了新动能。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1449228.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0251","159883","BK0239","BK1583","688366","BK1574","09996","BK1100"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640995802","title":"昊海生科(688366)披露因H股股份回购需通知债权人公告,6月1日股价上涨0.99%","url":"https://stock-news.laohu8.com/highlight/detail?id=2640995802","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2640995802?lang=zh_cn&edition=full","pubTime":"2026-06-01 18:15","pubTimestamp":1780308955,"startTime":"0","endTime":"0","summary":"截至2026年6月1日收盘,昊海生科报收于34.8元,较前一交易日上涨0.99%,最新总市值为80.03亿元。该股当日开盘34.32元,最高34.85元,最低33.77元,成交额达1913.49万元,换手率为0.29%。近日,上海昊海生物科技股份有限公司发布《因H股股份回购需通知债权人公告》。回购期限至2026年年度股东会结束或特别决议撤销授权之日止。回购完成后将注销股份并减少注册资本。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026060100029616.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1187483906","title":"昊海生科:侯永泰辞任执行董事、董事长","url":"https://stock-news.laohu8.com/highlight/detail?id=1187483906","media":"美股速递","labels":["executive"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1187483906?lang=zh_cn&edition=full","pubTime":"2026-05-29 22:18","pubTimestamp":1780064301,"startTime":"0","endTime":"0","summary":"昊海生科宣布,侯永泰先生已向公司董事会提交辞呈,辞去其担任的执行董事及董事长职务。公司董事会将依据相关法律法规及公司章程的规定,尽快启动新任董事长的选举程序,并确保公司治理结构的平稳过渡与日常运营的持续稳定。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2638378315","title":"5月25日昊海生科发布公告,股东减持77.47万股","url":"https://stock-news.laohu8.com/highlight/detail?id=2638378315","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2638378315?lang=zh_cn&edition=full","pubTime":"2026-05-25 19:01","pubTimestamp":1779706871,"startTime":"0","endTime":"0","summary":"证券之星消息,5月25日昊海生科发布公告《昊海生科:上海昊海生物科技股份有限公司股东减持股份结果公告》,其股东楼国梁于2026年2月26日至2026年5月25日间合计减持77.47万股,占公司目前总股本的0.3369%,变动期间该股股价下跌25.7%,截止5月25日收盘报34.41元。股东增减持详情见下表:根据昊海生科2026年一季报公布的十大股东详情如下:以上内容为证券之星据公开信息整理,不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026052500026908.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2636062967","title":"每周股票复盘:昊海生科(688366)累计购回374.89万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2636062967","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2636062967?lang=zh_cn&edition=full","pubTime":"2026-05-17 04:29","pubTimestamp":1778963349,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,昊海生科报收于36.82元,较上周的39.14元下跌5.93%。本周,昊海生科5月12日盘中最高价报39.99元。本周关注点公司公告汇总:昊海生科自2026年3月23日至5月15日累计购回3,748,900股H股,占决议通过当日已发行股份的9.4858%。H股公告:翌日披露报表上海昊海生物科技股份有限公司于2026年5月13日提交翌日披露报表,显示当日购回31,500股H股,每股价格介乎22.08至22.46港元,总代价为703,288港元。本次购回后30日内不得发行新股或出售库存股份。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051700001469.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635035835","title":"昊海生科(688366)披露H股股份购回进展,5月15日股价下跌1.07%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635035835","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635035835?lang=zh_cn&edition=full","pubTime":"2026-05-15 22:53","pubTimestamp":1778856790,"startTime":"0","endTime":"0","summary":"截至2026年5月15日收盘,昊海生科报收于36.82元,较前一交易日下跌1.07%,最新总市值为84.68亿元。该股当日开盘37.36元,最高37.67元,最低36.56元,成交额达2598.52万元,换手率为0.36%。近日,昊海生科披露H股股份购回进展公告。截至2026年5月15日,公司已发行H股股份总数仍为35,929,040股。购回授权于2025年6月10日获决议通过,可购回股份总数为3,914,184股,目前已购回3,748,900股。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051500044488.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635702143","title":"昊海生科风波再起:实控人涉嫌内幕交易,业绩断崖式下滑","url":"https://stock-news.laohu8.com/highlight/detail?id=2635702143","media":"新浪证券","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635702143?lang=zh_cn&edition=full","pubTime":"2026-05-15 16:56","pubTimestamp":1778835360,"startTime":"0","endTime":"0","summary":" 昊海生科近日公告,公司实际控制人之一蒋伟因涉嫌内幕交易被上海市公安局取保候审,期限自2026年4月29日起算。这已是蒋伟第二次因同一性质事件进入监管视野——2025年12月,证监会已就其内幕交易及建议他人买卖证券行为作出处罚,没收违法所得并罚款合计超过1900万元。公告发布当日,公司A股及H股双双收跌,显示出市场对实控人涉案的担忧并未消除。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-05-15/doc-inhxyimh8168674.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635871366","title":"昊海生科(688366)披露H股购回进展,5月14日股价下跌3.58%","url":"https://stock-news.laohu8.com/highlight/detail?id=2635871366","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2635871366?lang=zh_cn&edition=full","pubTime":"2026-05-14 18:03","pubTimestamp":1778752999,"startTime":"0","endTime":"0","summary":"截至2026年5月14日收盘,昊海生科报收于37.22元,较前一交易日下跌3.58%,最新总市值为85.6亿元。公司于近日披露H股购回进展:上海昊海生物科技股份有限公司于2026年5月13日提交翌日披露报表,显示当日购回31,500股H股,每股价格介乎22.08至22.46港元,总代价为703,288港元。截至2026年5月13日,公司已累计根据购回授权购回3,712,900股H股,占决议通过当日已发行股份的9.4858%。本次购回后30日内不得发行新股或出售库存股份。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051400034135.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2634925412","title":"每周股票复盘:昊海生科(688366)5月6日回购8.52万股H股","url":"https://stock-news.laohu8.com/highlight/detail?id=2634925412","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2634925412?lang=zh_cn&edition=full","pubTime":"2026-05-10 03:33","pubTimestamp":1778355191,"startTime":"0","endTime":"0","summary":"截至2026年5月8日收盘,昊海生科报收于39.14元,较上周的39.65元下跌1.29%。本周,昊海生科5月6日盘中最高价报39.83元。本周关注点公司公告汇总:昊海生科于2026年5月6日回购85,200股H股,每股价格介于21.6至22.12港元之间。公司公告汇总:截至2026年4月30日,公司尚未注销的购回H股总数为692,000股。2026年5月6日,公司购回85,200股H股,每股价格介于21.6港元至22.12港元,总代价1,871,110港元,该等股份拟予注销。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026051000001431.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["688366","BK0239","BK0251"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2633311472","title":"昊海生科(688366)发布H股翌日披露报表,5月6日单日回购85,200股H股,5月7日股价下跌0.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2633311472","media":"证券之星","labels":["shareholding","buyback"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2633311472?lang=zh_cn&edition=full","pubTime":"2026-05-07 17:46","pubTimestamp":1778147216,"startTime":"0","endTime":"0","summary":"截至2026年5月7日收盘,昊海生科报收于38.84元,较前一交易日下跌0.77%,最新总市值为89.32亿元。该股当日开盘39.12元,最高39.28元,最低38.8元,成交额达2285.59万元,换手率为0.3%。公司于近日发布H股翌日披露报表。公告显示,上海昊海生物科技有限公司于2026年5月6日购回85,200股H股,每股购回价介于21.6港元至22.12港元之间,总代价为1,871,110港元。公司确认相关购回符合上市规则要求,并注明购回授权决议通过日期为2025年6月10日,暂止期至2026年6月5日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050700029819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding,buyback","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2632625736","title":"每周股票复盘:昊海生科(688366)控股股东因内幕交易被取保候审","url":"https://stock-news.laohu8.com/highlight/detail?id=2632625736","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2632625736?lang=zh_cn&edition=full","pubTime":"2026-05-02 07:28","pubTimestamp":1777678093,"startTime":"0","endTime":"0","summary":"截至2026年4月30日收盘,昊海生科报收于39.65元,较上周的39.54元上涨0.28%。本周关注点公司公告汇总:控股股东、实际控制人之一蒋伟因涉嫌内幕交易被取保候审,该事项与公司无关。公司公告汇总上海昊海生物科技股份有限公司于近日收到控股股东、实际控制人之一蒋伟先生通知,因其涉嫌内幕交易案侦查所需,上海市公安局出具了《取保候审决定书》,决定对蒋伟先生取保候审,期限从2026年4月29日起算。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026050200003882.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172942844","title":"昊海生科:江伟未在公司担任董事、高级管理人员或其他任何职务","url":"https://stock-news.laohu8.com/highlight/detail?id=1172942844","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1172942844?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:45","pubTimestamp":1777553125,"startTime":"0","endTime":"0","summary":"昊海生科(股票代码:688366)发布声明,确认江伟先生目前未在公司担任董事、高级管理人员或任何其他职务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["688366","BK0251","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1180147907","title":"昊海生科回应江伟涉嫌内幕交易案调查","url":"https://stock-news.laohu8.com/highlight/detail?id=1180147907","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1180147907?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:39","pubTimestamp":1777552757,"startTime":"0","endTime":"0","summary":"上海昊海生物科技股份有限公司(股票代码:688366)近日就公司董事长江伟涉嫌内幕交易案件调查事宜作出正式回应。该事件已引发监管部门关注,目前公司正积极配合相关调查工作。\n根据公开信息显示,此次调查涉及公司重大信息披露期间的股票交易行为。昊海生科强调,公司将严格遵守证券市场法律法规,确保信息披露的及时性与准确性。公司日常经营及财务状况未受该事件影响,各项业务有序推进。\n作为生物科技领域的领军企业,昊海生科表示将持续完善内部治理结构,强化合规管理体系建设,切实维护投资者权益。市场人士指出,此类调查有助于促进资本市场健康稳定发展,对规范上市公司行为具有积极意义。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","BK0239","688366"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1171489970","title":"昊海生科实际控制人获上海市公安局取保候审","url":"https://stock-news.laohu8.com/highlight/detail?id=1171489970","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/1171489970?lang=zh_cn&edition=full","pubTime":"2026-04-30 20:39","pubTimestamp":1777552755,"startTime":"0","endTime":"0","summary":"上海昊海生科生物技术股份有限公司发布公告称,公司实际控制人已由上海市公安局执行取保候审。该事项涉及公司控股股东的相关情况,目前案件正在进一步审理中。公司表示将密切关注进展并及时履行信息披露义务。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2631432687","title":"昊海生科最新公告:控股股东之一因非本公司事项收到《取保候审决定书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2631432687","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2631432687?lang=zh_cn&edition=full","pubTime":"2026-04-30 18:10","pubTimestamp":1777543816,"startTime":"0","endTime":"0","summary":"昊海生科(688366.SH)公告称,公司控股股东、实际控制人之一蒋伟因涉嫌内幕交易案,收到上海市公安局出具的《取保候审决定书》,期限从2026年4月29日起算。此前蒋伟已于2025年12月因内幕交易等行为收到证监会《行政处罚决定书》。该事项与公司无关,蒋伟未在公司任职,不会影响公司日常经营。以上内容为证券之星据公开信息整理,由AI算法生成(网信算备310104345710301240019号),不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026043000058721.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0251","688366","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2630566302","title":"医美上市企业2025年业绩集体承压!爱美客、昊海生科、巨子生物等营收、净利双降","url":"https://stock-news.laohu8.com/highlight/detail?id=2630566302","media":"红星资本局","labels":[],"top":-1,"itemType":null,"share":"https://www.laohu8.com/m/news/2630566302?lang=zh_cn&edition=full","pubTime":"2026-04-28 20:24","pubTimestamp":1777379070,"startTime":"0","endTime":"0","summary":"红星资本局4月28日消息,近日,多家医美上市企业陆续交出2025年的“成绩单”。红星资本局注意到,多家龙头医美企业踩下业绩高增长的“急刹车”,出现营收、净利双降的情况;也有企业困于单一品牌,给业绩增长带来难题。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202604283722723751.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["02367","688366","300896","IPOS"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1783046215022,"stockEarnings":[{"period":"1week","weight":0.033},{"period":"1month","weight":-0.0884},{"period":"3month","weight":-0.1956},{"period":"6month","weight":-0.2884},{"period":"1year","weight":-0.3783},{"period":"ytd","weight":-0.2884}],"compareEarnings":[{"period":"1week","weight":-0.0222},{"period":"1month","weight":-0.0113},{"period":"3month","weight":0.0384},{"period":"6month","weight":0.0151},{"period":"1year","weight":0.1662},{"period":"ytd","weight":0.0151}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"上海昊海生物科技股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"0人","perCapita":"--","listingDate":"2019-10-30","address":"上海市松江区松江工业区洞泾路5号","registeredCapital":"22883万元","survey":" 上海昊海生物科技股份有限公司的主营业务是医疗器械和药品研发、生产和销售业务。公司的主要产品是医疗美容与创面护理产品、眼科产品、骨科关节腔粘弹补充剂产品、防粘连及止血产品。本集团的医用几丁糖专利技术先后获得“上海市技术发明一等奖”和“国家科学技术进步奖二等奖”,生产出国际上第一个成功应用于人体内的医用几丁糖产品;外用人表皮生长因子产品获得“国家科学技术进步奖二等奖”,是国际第一个获得注册的外用人表皮生长因子产品;本集团参与研发的“生物适配防粘连材料的关键技术及临床应用”项目获得上海市技术发明奖一等奖。","listedPrice":89.23},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"昊海生科(688366)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供昊海生科(688366)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"昊海生科,688366,昊海生科股票,昊海生科股票老虎,昊海生科股票老虎国际,昊海生科行情,昊海生科股票行情,昊海生科股价,昊海生科股市,昊海生科股票价格,昊海生科股票交易,昊海生科股票购买,昊海生科股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"昊海生科(688366)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供昊海生科(688366)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}